A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)

NCT00813995 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

395

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Comparator: Sitagliptin phosphate
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC